This SPA amends the reimbursement methodology for bio-engineered substitutes (skin graft) to the lower of the amount billed, the charge to the general public, or 100 percent of corresponding Medicare Average Sales Price (ASP) rate.
State
Topics
Approval Date
Effective Date
File 1 - Approval Document Media